Pilot Study to Examine the Acute Impact of Veillonella Supplementation on

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the health and performance outcomes associated with supplementation of Veillonella atypica.

Clinical Trial Description

This pilot study will be conducted using a randomized, double-blind, crossover study design. Healthy men and women (n=7) between the ages of 18 - 50 years of age will be recruited for this study. After signing an IRB-approved consent form, participants will have their peak VO2 determined to finalize eligibility. Eligible participants will then practice their first time to exhaustion trial at 100% VO2Peak. Prior to each subsequent study visit, participants will be scheduled at a similar time between the hours of 0600 and 1000 hours and will be asked to observe an overnight fast (food, caffeine, and nicotine) while refraining from any vigorous exercise for at least 24 hours prior to their visit. During visit 2, participants will have their body composition assessed and complete another time to exhaustion familiarization at 100% VO2Peak. Leading up to and during each subsequent study visit (identical to visit 3), participants will collect a stool sample and upon arrival at the laboratory have their body mass measured before having a venous blood sample collected for assessment of complete blood count and comprehensive metabolic panel. After blood collection, participants will complete the standardized warm-up before completing a treadmill time to exhaustion test at 100% VO2Peak. Capillary lactate levels will be assessed before, immediately after, and 5 minutes after completion of the exhaustion trial using a handheld lactate analyzer. From there and in a randomized, double-blind, placebo-controlled, crossover fashion, participants will be assigned for the next 14 days to ingest either a placebo (maltodextrin) or a 1 x 109CFU dose of Veillonella atypica FB004 (VA) (Fitbiomics, Inc. New York). After supplementing for 14 days, participants will complete an identical battery of tests. Participants will then follow a wash-out period for 21 days before returning to the laboratory to complete study visit 5, the pre-supplementation visit to their supplementation period. After completing study visit 5, participants will be instructed to supplement with the alternative supplement for 14 days before returning for a 6th and final study visit. Participants will complete a two-day food and fluid record prior to visit 3, receivea copy of it from study investigators, and be instructed to replicate it prior to each subsequent study visit. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05816291
Study type	Interventional
Source	Lindenwood University
Contact
Status	Completed
Phase	N/A
Start date	March 30, 2022
Completion date	July 26, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05108467` - Saving Lives by Early Detection and Treatment of Sepsis and Septic Shock by Point of Care Lactate Test in Adults
Completed	`NCT04641104` - The Thiamine Administration After Cardiac Surgery Trial	Phase 4
Not yet recruiting	`NCT03115970` - Feasibility of Lactate Level Evaluation in Prehospital Care in Trauma	N/A
Recruiting	`NCT03831685` - Blood Lactate Level for Pre-hospital Orientation of Septic Shock
Completed	`NCT03974906` - Goal-directed Fluid Therapy in Elderly Patients Undergoing Lumbar Surgery	N/A
Not yet recruiting	`NCT03980678` - Lithothamnion Species on Blood Lactate During Exhaustive Exercise in Trained Cyclists	N/A
Completed	`NCT04777747` - The Role of Lactate in Viral and Bacterial Infection
Completed	`NCT05611398` - Lactate Monitoring in Traumatic Long Bone Fractures Requiring Emergent Surgical Intervention
Recruiting	`NCT03062683` - Serum Lactate in Convulsive Syncopes Compared to Non-convulsive Syncopes	N/A
Completed	`NCT05295836` - Effects of Acute Glycerol Ingestion on Performance, Metabolic and Biochemical Markers in International Athletes	N/A
Completed	`NCT06292910` - Central Venous to Arterial CO2 Difference and Low Cardiac Output Syndrome Related Outcomes in Children After Cardiac Surgery
Active, not recruiting	`NCT04796285` - A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Pilot Study to Examine the Acute Impact of Veillonella Supplementation on Exercise and Lactate Responses — VP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms